Bixiye
bc-mhcp-pharmprogpolicynotifctn-final-eff-7.1.23-post-6.17.23.pdf
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 791 - 800 ee natiijooyinka 3607
Bixiye
QP48-23 Update for New to Market Medical Drugs: delandistrogene moxeparvovec and epcoritamab
Taariikhda wax ku ool ah ee barnaamijka: Jun 14, 2023
Bixiye
QP49-23 Register for Webinar | Trauma-Informed Care 101 | Thursday, June 29, 5-6:30 pm
Taariikhda wax ku ool ah ee barnaamijka: Jun 14, 2023
Bixiye
QP50-23 Fetal Alcohol Syndrome Education Opportunity
Taariikhda wax ku ool ah ee barnaamijka: Jun 14, 2023
Bixiye
QP51-23 Commercial Pharmacy Benefit Exclusion for Aponvie™, Iheezo™, Omisirge®, and Qalsody™
Taariikhda wax ku ool ah ee barnaamijka: Jun 14, 2023
Bixiye
QP52-23 MHCP Pharmacy Benefit Exclusion for Iheezo™, Omisirge®, and Qalsody™
Taariikhda wax ku ool ah ee barnaamijka: Jun 14, 2023
Bixiye
QP53-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2023
Taariikhda wax ku ool ah ee barnaamijka: Jun 14, 2023
Bixiye
QP54-23 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2023
Taariikhda wax ku ool ah ee barnaamijka: Jun 14, 2023
Bixiye
QP55-23 Change in Processing for Replacement Claims
Taariikhda wax ku ool ah ee barnaamijka: Jun 14, 2023
Faa'iidooyinka & Caymiska
2023 Blue Cross Dental Plans Individual and Family Plan Rates